Color Vision Defects
Recent clinical, regulatory, research and industry developments relating to this disease.
Endoplasmic reticulum stress: molecular mechanism and therapeutic targets.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes3
- Color Vision Defects1
- Endoplasmic Reticulum Stress1
- Visual Acuity1
Leading journals2
- JAMA ophthalmology1
- Signal transduction and targeted therapy1
Leading researchers8
- Bartz-Schmidt KU1
- Biel M1
- Chen X1
- Dauletbekov D1
- Fischer MD1
- Garcia-Garrido M1
- He M1
- Kahle N1
Affiliations (unnormalised)6
- Center for Integrated Protein Science Munich1
- Centre for Ophthalmology1
- College of Physicians and Surgeons1
- Eye Center of Xiangya Hospital1
- Hunan Key Laboratory of Ophthalmology1
- Institute for Clinical Epidemiology and Applied Biostatistics1
Reference
Authoritative identity, definition & identifiers.
Defects of color vision are mainly hereditary traits but can be secondary to acquired or developmental abnormalities in the CONES (RETINA). Severity of hereditary defects of color vision depends on the degree of mutation of the ROD OPSINS genes (on X CHROMOSOME and CHROMOSOME 3) that code the photopigments for red, green and blue.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.